Antibody cocktails could steer viruses into evolutionary dead ends
When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS-CoV-2 can slip past vaccines and antibody drugs before scientists fully understand what has changed. A new study from Harvard's Department of Chemistry and Chemical Biology (CCB) suggests the hard way may...
September 14, 2026105 views
Image: Phys.org
When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS-CoV-2 can slip past vaccines and antibody drugs before scientists fully understand what has changed. A new study from Harvard's Department of Chemistry and Chemical Biology (CCB) suggests the hard way may not be inevitable.
Be the first to receive the latest news, market analysis and updates — delivered straight to your inbox.
We value your privacy
We use cookies to run this site and, with your consent, to measure
traffic and improve our content. Necessary cookies are always on. You
can accept all cookies or choose which ones to allow.
Privacy policy.